http://www.pharmabiz.com/NewsDetails.aspx?aid=79986&sid=2 Witryna10 cze 2015 · proprietary Nanotecton™ platform technology PICN as supplied PICN as admixture Electron microscope image of nanoparticle 50 nm –150 nm in size Cremophor®and Albumin free formulation 30 minute infusion No standard Paclitaxel pre-medications required Allows higher dose than Taxol®
Phase I study of docetaxel injection concentrate for nano …
WitrynaNanotecton™ Technology. SPARC’s proprietary Nano-dispersion technology is based on forming a complex of drug ... View Details. Witryna1 gru 2024 · 1. Paclitaxel formulations: big money deals and promising data. Large pharmaceutical and small biotech companies (18 in total, Fig. 1) have pursued formulation development, manufacturing, acquisition of distribution rights and/or company mergers with a goal towards conquering the paclitaxel (PTX) market. Funds … state information commission chhattisgarh
SPARC declines after USFDA denies application for cancer drug
Witryna7 lip 2015 · Based on SUN PHARMA ADVANCED RESEARCH COMPANY, the NANOTECTON trademark is used in the following business: Development of new … Witrynananotecton . 2015-01-13 "elepsia" 86405554. elepsia . 2014-09-25 "xelpros" 86307459. xelpros . 2014-06-12 "nanotecton" 5905997 85744325. nanotecton . 2012-10-03. company registrations. ncage code: 2825y: sun pharma advanced research company ltd: ncage code: snn26: sun pharma advanced research company ltd Witryna20 maj 2013 · Background: PICN is a novel Cremaphor-free composite of paclitaxel nano-particles stabilized with polymer and lipid using Nanotecton Technology. The … state information commission chandigarh